Skip to main content
Mayinglong Pharmaceutical Group Co.,Ltd logo

Mayinglong Pharmaceutical Group Co.,Ltd — Investor Relations & Filings

Ticker · 600993 ISIN · CNE000001HN2 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 931 across all filing types
Latest filing 2009-06-07 Notice of Dividend Amou…
Country CN China
Listing Shanghai Stock Exchange 600993

About Mayinglong Pharmaceutical Group Co.,Ltd

https://www.mayinglong.cn/

Mayinglong Pharmaceutical Group Co.,Ltd. is a long-established enterprise specializing in the research, development, and production of Traditional Chinese Medicine (TCM). Founded in 1582, the company is widely recognized for its expertise in proctology, maintaining a dominant market position with its signature hemorrhoid ointments and suppositories. Its product portfolio also includes ophthalmic preparations, dermatological treatments, and gastrointestinal medicines. The company integrates traditional medicinal formulas with modern manufacturing technologies to provide healthcare solutions. Beyond pharmaceuticals, Mayinglong has expanded into healthcare services, including specialized hospitals and personal care products, focusing on the integration of clinical treatment and health management.

Recent filings

Filing Released Lang Actions
2008年利润分配及公积金转增股本实施公告
Notice of Dividend Amount Classification · 95% confidence The document is titled as an announcement regarding the implementation of profit distribution and capital reserve conversion to share capital for the year 2008 by the company 马应龙药业集团股份有限公司. It details the dividend per share, share bonus, record dates, ex-dividend dates, and the total shares after the increase. It also mentions the shareholders' meeting date when the plan was approved. The document is an announcement of the dividend and share capital increase implementation, not a full annual report or financial statement. It is relatively short (2343 characters) and focuses on dividend distribution and share capital changes. This fits the definition of a Notice of Dividend Amount (DIV) filing, as it announces dividend amounts, payment dates, and related details for shareholders.
2009-06-07 Chinese
2008年度股东大会的法律意见书
AGM Information Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the legality and validity of the 2008 Annual General Meeting (AGM) of 马应龙药业集团股份有限公司. It discusses the convening, attendance, voting procedures, and results of the AGM. The document is not the AGM materials or presentations themselves, but a legal opinion related to the AGM. Given the content and the nature of the document, it fits best under AGM Information (AGM-R), which includes presentations and materials shared during the AGM, including legal opinions related to the meeting. The document length is short (1482 characters), but it is a substantive legal opinion, not merely an announcement of a report, so it is not an RPA or RNS. Therefore, the classification is AGM-R with high confidence.
2009-06-02 Chinese
2008年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a resolution announcement for the 2008 Annual General Meeting (AGM) of the company 马应龙药业集团股份有限公司. It details the meeting date, attendance, and the voting results on various proposals including the 2008 annual reports, financial statements, profit distribution, auditor appointment, and amendments to the company bylaws. The document is a formal announcement of the AGM resolutions and voting outcomes rather than the full AGM materials or the annual report itself. The length is short (1720 characters), and it serves as an official disclosure of the AGM decisions. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2009-06-02 Chinese
2008年年度股东大会会议资料
AGM Information Classification · 100% confidence The document is titled as materials for the 2008 Annual General Meeting (AGM) of the company 马应龙药业集团股份有限公司. It contains detailed reports and proposals to be discussed and voted on at the AGM, including the 2008 Board of Directors work report, independent directors' report, supervisory board report, financial statements, annual report and summary, profit distribution plan, appointment of auditors, and amendments to the company charter. The document also includes the meeting agenda, voting procedures, and shareholder rights, which are typical contents of AGM information materials. The document length is over 13,000 characters, indicating it is a full set of meeting materials rather than a brief announcement. Therefore, this document fits the category of AGM Information (AGM-R).
2009-05-23 Chinese
第六届董事会第十二次会议决议公告暨召开公司2008年年度股东大会的通知
AGM Information Classification · 95% confidence The document is an announcement of the resolutions passed at the 12th meeting of the 6th Board of Directors and the notice of the 2008 Annual General Meeting (AGM) of shareholders. It includes details about the AGM date, location, agenda items (such as approval of the 2008 annual reports and financial statements), and procedures for attendance and voting. The document does not contain the actual annual report or financial statements but rather announces the meeting and its agenda. The document length is 2380 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2009-05-06 Chinese
第六届监事会第九次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Mayinglong Pharmaceutical Group Co., Ltd. It reports the approval of the 2008 Annual Report and Summary, the 2008 Supervisory Board Work Report, and the 2009 First Quarter Report. The document is short (939 characters) and primarily announces the passing of these reports by the Supervisory Board, stating that these reports comply with relevant laws and regulations. It does not contain the full reports themselves but rather the resolutions approving them. Therefore, this document is an announcement of the approval of reports, not the reports themselves. According to the 'Menu vs Meal' rule, such a document should be classified as a Regulatory Filing (RNS) because it is a formal announcement related to regulatory compliance and report approvals but does not contain substantive financial data or the full reports.
2009-04-25 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.